FdaApplication

BLA 125748

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGlaxoSmithKline Biologicals
application_typeBLA
approval_date2022-06-03

Products (1)

ProductActive ingredientStrengthDosage form
PRIORIX—3.4, 4.2 and 3.3LOG10For Injection

1 product